Cumberland Pharmaceuticals Names John Hamm New Main Fiscal Officer
2 min readHamm has far more than 25 decades of finance and accounting practical experience, like 20 many years in overall health care. He previously served as Cumberland’s Director Company Improvement, exactly where he was responsible for small business advancement, alliance management and legal functions.
“In the past two a long time, John has tested himself to be an integral portion of our staff here at Cumberland,” claimed A.J. Kazimi, main govt officer of Cumberland Prescription drugs. “We’re self-confident he’ll keep on to provide our company with the highest integrity and enable advance our mission of bettering patient treatment by way of the shipping of significant-high-quality medications.”
Prior to signing up for Cumberland in 2019, Hamm served in senior govt positions in the well being treatment, broadcasting and telecom industries. Hamm is the former Chief Working Officer at HealthSpring and Main Financial Officer for their pharmacy business enterprise. HealthSpring, a managed care organization, now operates as Cigna-HealthSpring.
He also is the previous Vice President Finance at Emdeon Company Providers, a overall health treatment know-how business now functioning as Transform Healthcare Inc. – a NASDAQ mentioned organization with around $3 billion in once-a-year revenues. He started his govt profession as Vice President, Controller at Viacom.
Hamm attained his bachelor’s degree in enterprise administration with a minor in accounting from Wheeling College. Moreover, he acquired his master’s degree in business administration with an emphasis in accounting from West Virginia University. Hamm is a Licensed Management Accountant (CMA) and Accredited Financial Manager (CFM).
About Cumberland Prescribed drugs
Cumberland Prescription drugs Inc. is a specialty pharmaceutical enterprise focused on the delivery of significant-top quality prescription manufacturers to make improvements to affected person care. The business develops, acquires and commercializes makes for the hospital acute treatment, gastroenterology and rheumatology current market segments. These professional medical specialties are classified by moderately concentrated prescriber bases that the business thinks can be penetrated correctly by focused income forces.
The firm’s portfolio of Food and drug administration-authorised models includes:
- Caldolor® (ibuprofen) Injection, for the remedy of soreness and fever
- Kristalose® (lactulose) for Oral Resolution, a prescription laxative, for the remedy of constipation
- Vibativ® (telavancin) Injection, for the remedy of certain serious bacterial infections including hospital-obtained and ventilator-affiliated bacterial pneumonia, as perfectly as sophisticated pores and skin and pores and skin framework bacterial infections
- RediTrex® (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and serious psoriatic arthritis, as perfectly as disabling psoriasis
- Vaprisol® (conivaptan) Injection, to elevate serum sodium amounts in hospitalized clients with euvolemic and hypervolemic hyponatremia
- Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the therapy of Helicobacter pylori (H. pylori) infection and similar duodenal ulcer disorder and
- Acetadote® (acetylcysteine) Injection, for the cure of acetaminophen poisoning.
For additional details on Cumberland’s permitted items, such as comprehensive prescribing facts, remember to stop by back links to the unique solution websites, which can be located on the company’s web site at www.cumberlandpharma.com.
Resource Cumberland Pharmaceuticals Inc.
